Abstract
A 45-year-old woman presented with a left-sided neck swelling following treatment a year prior for cervical spine chordoma. She had initially been managed surgically with a cervical vertebrectomy and a course of proton beam therapy. Although there had been a degree of residual tissue, her disease remained stable radiologically and clinically. Repeat MRI demonstrated an increasing left paravertebral mass and a head of pancreas metastasis, which shared pathological characteristics with chordoma. Given the advanced metastatic nature of her disease, imatinib was offered with a palliative intent. While waiting for treatment she developed a spinal cord compression, managed with radiotherapy. She commenced imatinib and her disease remained stable for 9 months before progressing clinically and radiologically. This case demonstrates an unusual pattern of metastatic chordoma and provides further rationale for imatinib in such patients.
| Original language | English |
|---|---|
| Article number | e240062 |
| Journal | BMJ Case Reports |
| Volume | 15 |
| Issue number | 1 |
| Early online date | 19 Jan 2022 |
| DOIs | |
| Publication status | Published - 19 Jan 2022 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- cancer intervention
- malignant disease and immunosuppression
- oncology
- pharmacology and therapeutics
- tyrosine kinase inhibitor
Fingerprint
Dive into the research topics of 'Metastatic chordoma with pancreatic disease and response to imatinib'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver